Australia's Perpetual rejects improved BPEA EQT, Regal bid
BPEA EQT – formerly Baring Private Equity Asia – and Regal Partners have increased their offer for Australia-based asset manager Perpetual only for the target company’s board to reject them once again.
Having seen an offer of AUD 30.00 per share turned down last week, the consortium revised its bid upwards to AUD 33.00 per share, putting an approximately AUD 1.9bn (USD 1.2bn) valuation on the company....
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.